1. Home
  2. PCRX vs PACK Comparison

PCRX vs PACK Comparison

Compare PCRX & PACK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PCRX
  • PACK
  • Stock Information
  • Founded
  • PCRX 2006
  • PACK 1972
  • Country
  • PCRX United States
  • PACK United States
  • Employees
  • PCRX N/A
  • PACK N/A
  • Industry
  • PCRX Biotechnology: Pharmaceutical Preparations
  • PACK Containers/Packaging
  • Sector
  • PCRX Health Care
  • PACK Consumer Discretionary
  • Exchange
  • PCRX Nasdaq
  • PACK Nasdaq
  • Market Cap
  • PCRX 604.7M
  • PACK 516.0M
  • IPO Year
  • PCRX 2011
  • PACK N/A
  • Fundamental
  • Price
  • PCRX $16.52
  • PACK $6.65
  • Analyst Decision
  • PCRX Buy
  • PACK Buy
  • Analyst Count
  • PCRX 10
  • PACK 2
  • Target Price
  • PCRX $26.60
  • PACK $8.50
  • AVG Volume (30 Days)
  • PCRX 545.3K
  • PACK 296.5K
  • Earning Date
  • PCRX 11-06-2024
  • PACK 10-31-2024
  • Dividend Yield
  • PCRX N/A
  • PACK N/A
  • EPS Growth
  • PCRX N/A
  • PACK N/A
  • EPS
  • PCRX N/A
  • PACK N/A
  • Revenue
  • PCRX $694,957,000.00
  • PACK $354,300,000.00
  • Revenue This Year
  • PCRX $4.59
  • PACK $10.48
  • Revenue Next Year
  • PCRX N/A
  • PACK $9.59
  • P/E Ratio
  • PCRX N/A
  • PACK N/A
  • Revenue Growth
  • PCRX 4.40
  • PACK 8.91
  • 52 Week Low
  • PCRX $11.16
  • PACK $3.70
  • 52 Week High
  • PCRX $35.95
  • PACK $9.04
  • Technical
  • Relative Strength Index (RSI)
  • PCRX 44.28
  • PACK 55.19
  • Support Level
  • PCRX $16.11
  • PACK $6.53
  • Resistance Level
  • PCRX $18.34
  • PACK $7.35
  • Average True Range (ATR)
  • PCRX 0.83
  • PACK 0.33
  • MACD
  • PCRX -0.17
  • PACK 0.05
  • Stochastic Oscillator
  • PCRX 5.33
  • PACK 55.41

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company has three commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve.

About PACK Ranpak Holdings Corp

Ranpak Holdings Corp is a provider of environmentally sustainable, systems-based, product protection solutions for e-Commerce and industrial supply chains. The company offers a full suite of protective packaging systems and paper consumables. Geographically, it derives a majority of revenue from Europe/Asia. They generate revenue by providing its PPS systems and paper consumables to customers, which include direct end-users and our network of exclusive paper packaging solution distributors, and by providing end-of-line automation systems that solve challenges, including optimization, customization, and efficiency.

Share on Social Networks: